Synbio Details Dual Growth Plan, Healing Force Launch
Synbio outlined a dual-track plan: commercial rollout of Healing Force nutraceuticals via a U.S./Canada licensing deal and a clinical pathway for FacialDx's NIMS facial-analysis mental health screening, aiming for an Australian feasibility study and non-dilutive funding.